SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Imboden JB. The immunopathogenesis of rheumatoid arthritis. Annu Rev Pathol 2009; 4: 41734.
  • 2
    Rosloniec EF, Whittington KB, Zaller DM, Kang AH. HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen. J Immunol 2002; 168: 2539.
  • 3
    Fugger L, Rothbard JB, Sonderstrup-McDevitt G. Specificity of an HLA-DRB1*0401-restricted T cell response to type II collagen. Eur J Immunol 1996; 26: 92833.
  • 4
    Andersson EC, Hansen BE, Jacobsen H, Madsen LS, Andersen CB, Engberg J, et al. Definition of MHC and T cell receptor contacts in the HLA-DR4 restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice. Proc Natl Acad Sci U S A 1998; 95: 75749.
  • 5
    Rosloniec EF, Brand DD, Myers LK, Esaki Y, Whittington KB, Zaller DM, et al. Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen. J Immunol 1998; 160: 25738.
  • 6
    Rosloniec EF, Brand DD, Myers LK, Whittington KB, Gumanovskaya M, Zaller DM, et al. An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen. J Exp Med 1997; 185: 111322.
  • 7
    Michaelsson E, Andersson M, Engstrom A, Holmdahl R. Identification of an immunodominant type-II collagen peptide recognized by T cells in H-2q mice: self tolerance at the level of determinant selection. Eur J Immunol 1992; 22: 181925.
  • 8
    Snir O, Widhe M, von Spee C, Lindberg J, Padyukov L, Lundberg K, et al. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles. Ann Rheum Dis 2009; 68: 73643.
  • 9
    Uysal H, Bockermann R, Nandakumar KS, Sehnert B, Bajtner E, Engstrom A, et al. Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis. J Exp Med 2009; 206: 44962.
  • 10
    Dzhambazov B, Holmdahl M, Yamada H, Lu S, Vestberg M, Holm B, et al. The major T cell epitope on type II collagen is glycosylated in normal cartilage but modified by arthritis in both rats and humans. Eur J Immunol 2005; 35: 35766.
  • 11
    Yamada H, Dzhambazov B, Bockermann R, Blom T, Holmdahl R. A transient post-translationally modified form of cartilage type II collagen is ignored by self-reactive T cells. J Immunol 2004; 173: 472935.
  • 12
    Backlund J, Carlsen S, Hoger T, Holm B, Fugger L, Kihlberg J, et al. Predominant selection of T cells specific for the glycosylated collagen type II epitope (263–270) in humanized transgenic mice and in rheumatoid arthritis. Proc Natl Acad Sci U S A 2002; 99: 99605.
  • 13
    Backlund J, Treschow A, Bockermann R, Holm B, Holm L, Issazadeh-Navikas S, et al. Glycosylation of type II collagen is of major importance for T cell tolerance and pathology in collagen-induced arthritis. Eur J Immunol 2002; 32: 377684.
  • 14
    Andersson M, Holmdahl R. Analysis of type II collagen-reactive T cells in the mouse. I. Different regulation of autoreactive vs. non-autoreactive anti-type II collagen T cells in the DBA/1 mouse. Eur J Immunol 1990; 20: 10616.
  • 15
    Broddefalk J, Backlund J, Almqvist F, Johansson M, Holmdahl R, Kihlberg J. T cells recognize a glycopeptide derived from type II collagen in a model for rheumatoid arthritis. J Am Chem Soc 1998; 120: 767683.
  • 16
    Holm B, Broddefalk J, Flodell S, Wellner E, Kihlberg J. An improved synthesis of a galactosylated hydroxylysine building block and its use in solid-phase glycopeptide synthesis. Tetrahedron 2000; 56: 157986.
  • 17
    Fugger L, Michie SA, Rulifson I, Lock CB, McDevitt GS. Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region β-chain T-cell repertoire and mediates an HLA-DR-restricted immune response. Proc Natl Acad Sci U S A 1994; 91: 61515.
  • 18
    Malmstrom V, Ho KK, Lun J, Tam PP, Cheah KS, Holmdahl R. Arthritis susceptibility in mice expressing human type II collagen in cartilage. Scand J Immunol 1997; 45: 6707.
  • 19
    Cosgrove D, Gray D, Dierich A, Kaufman J, Lemeur M, Benoist C, et al. Mice lacking MHC class II molecules. Cell 1991; 66: 105166.
  • 20
    Malmstrom V, Michaelsson E, Burkhardt H, Mattsson R, Vuorio E, Holmdahl R. Systemic versus cartilage-specific expression of a type II collagen-specific T-cell epitope determines the level of tolerance and susceptibility to arthritis. Proc Natl Acad Sci U S A 1996; 93: 44805.
  • 21
    Hultqvist M, Backlund J, Bauer K, Gelderman KA, Holmdahl R. Lack of reactive oxygen species breaks T cell tolerance to collagen type II and allows development of arthritis in mice. J Immunol 2007; 179: 14317.
  • 22
    Hultqvist M, Olofsson P, Holmberg J, Backstrom BT, Tordsson J, Holmdahl R. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc Natl Acad Sci U S A 2004; 101: 1264651.
  • 23
    Holmdahl R, Carlsen S, Mikulowska A, Vestberg M, Brunsberg U, Hansson A, et al. Genetic analysis of mouse models for rheumatoid arthritis. New York: CRC Press; 1998.
  • 24
    Holmdahl R, Klareskog L, Andersson M, Hansen C. High antibody response to autologous type II collagen is restricted to H-2q. Immunogenetics 1986; 24: 849.
  • 25
    Morgado MG, Cam P, Gris-Liebe C, Cazenave PA, Jouvin-Marche E. Further evidence that BALB/c and C57BL/6 γ2a genes originate from two distinct isotypes. EMBO J 1989; 8: 324551.
  • 26
    White J, Blackman M, Bill J, Kappler J, Marrack P, Gold DP, et al. Two better cell lines for making hybridomas expressing specific T cell receptors. J Immunol 1989; 143: 18225.
  • 27
    Kjellen P, Brunsberg U, Broddefalk J, Hansen B, Vestberg M, Ivarsson I, et al. The structural basis of MHC control of collagen-induced arthritis; binding of the immunodominant type II collagen 256-270 glycopeptide to H-2Aq and H-2Ap molecules. Eur J Immunol 1998; 28: 75567.
  • 28
    Backlund J, Nandakumar KS, Bockermann R, Mori L, Holmdahl R. Genetic control of tolerance to type II collagen and development of arthritis in an autologous collagen-induced arthritis model. J Immunol 2003; 171: 34939.
  • 29
    Hammer J, Belunis C, Bolin D, Papadopoulos J, Walsky R, Higelin J, et al. High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations. Proc Natl Acad Sci U S A 1994; 91: 445660.
  • 30
    Sakurai Y, Brand DD, Tang B, Rosloniec EF, Stuart JM, Kang AH, et al. Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice. Arthritis Res Ther 2006; 8: R150.
  • 31
    Hultqvist M, Olsson LM, Gelderman KA, Holmdahl R. The protective role of ROS in autoimmune disease. Trends Immunol 2009; 30: 2018.
  • 32
    Nandakumar KS, Svensson L, Holmdahl R. Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes. Am J Pathol 2003; 163: 182737.
  • 33
    Lewkowich IP, Lajoie S, Clark JR, Herman NS, Sproles AA, Wills-Karp M. Allergen uptake, activation, and IL-23 production by pulmonary myeloid DCs drives airway hyperresponsiveness in asthma-susceptible mice. PLoS One 2008; 3: e3879.
  • 34
    Mo JA, Bona CA, Holmdahl R. Variable region gene selection of immunoglobulin G-expressing B cells with specificity for a defined epitope on type II collagen. Eur J Immunol 1993; 23: 250310.
  • 35
    Mo JA, Holmdahl R. The B cell response to autologous type II collagen: biased V gene repertoire with V gene sharing and epitope shift. J Immunol 1996; 157: 24408.
  • 36
    Wernhoff P, Unger C, Bajtner E, Burkhardt H, Holmdahl R. Identification of conformation-dependent epitopes and V gene selection in the B cell response to type II collagen in the DA rat. Int Immunol 2001; 13: 90919.
  • 37
    Akkaraju S, Ho WY, Leong D, Canaan K, Davis MM, Goodnow CC. A range of CD4 T cell tolerance: partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis. Immunity 1997; 7: 25571.
  • 38
    McLachlan SM, Nagayama Y, Pichurin PN, Mizutori Y, Chen CR, Misharin A, et al. The link between Graves' disease and Hashimoto's thyroiditis: a role for regulatory T cells. Endocrinology 2007; 148: 572433.
  • 39
    Malmstrom V, Backlund J, Jansson L, Kihlberg J, Holmdahl R. T cells that are naturally tolerant to cartilage-derived type II collagen are involved in the development of collagen-induced arthritis. Arthritis Res 2000; 2: 31526.
  • 40
    Campbell IK, Kinkel SA, Drake SF, van Nieuwenhuijze A, Hubert FX, Tarlinton DM, et al. Autoimmune regulator controls T cell help for pathogenetic autoantibody production in collagen-induced arthritis. Arthritis Rheum 2009; 60: 168393.
  • 41
    Chin RK, Zhu M, Christiansen PA, Liu W, Ware C, Peltonen L, et al. Lymphotoxin pathway-directed, autoimmune regulator-independent central tolerance to arthritogenic collagen. J Immunol 2006; 177: 2907.
  • 42
    Von Delwig A, Altmann DM, Charlton FG, McKie N, Isaacs JD, Holmdahl R, et al. T cell responses to a non-glycosylated epitope predominate in type II collagen-immunised HLA-DRB1*0101 transgenic mice. Ann Rheum Dis 2007; 66: 599604.
  • 43
    Von Delwig A, Altmann DM, Isaacs JD, Harding CV, Holmdahl R, McKie N, et al. The impact of glycosylation on HLA–DR1– restricted T cell recognition of type II collagen in a mouse model. Arthritis Rheum 2006; 54: 48291.
  • 44
    Holm B, Baquer SM, Holm L, Holmdahl R, Kihlberg J. Role of the galactosyl moiety of collagen glycopeptides for T-cell stimulation in a model for rheumatoid arthritis. Bioorg Med Chem 2003; 11: 39817.
  • 45
    Michaelsson E, Broddefalk J, Engstrom A, Kihlberg J, Holmdahl R. Antigen processing and presentation of a naturally glycosylated protein elicits major histocompatibility complex class II-restricted, carbohydrate-specific T cells. Eur J Immunol 1996; 26: 190610.
  • 46
    Dessen A, Lawrence CM, Cupo S, Zaller DM, Wiley DC. X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II. Immunity 1997; 7: 47381.
  • 47
    Rosloniec EF, Whittington KB, He X, Stuart JM, Kang AH. Collagen-induced arthritis mediated by HLA-DR1 (*0101) and HLA-DR4 (*0401). Am J Med Sci 2004; 327: 16979.